RE: Putting patients first to redefine prostate cancer classifications: patients' viewpoints on redefining Grade Group 1

被引：1
|
作者：
Wolinsky, Howard [1 ,2 ]
机构：
[1] AnCan Fdn, Virtual Support Grp Act Surveillance, Chicago, IL USA
[2] AnCan Fdn, Act Surveillor Newsletter, 2050 Collett Ln, Flossmoor, IL 60422 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2023年 / 115卷 / 10期
关键词：
D O I：
10.1093/jnci/djad160
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1236 / 1236
页数：1
相关论文
共 50 条
  • [1] Putting patients first to redefine prostate cancer classifications
    Nyame, Yaw A.
    Gore, John L.
    Lin, Daniel W.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (11): : 1249 - 1251
  • [2] Success of targeted transperineal biopsy in patients on surveillance for grade group 1 prostate cancer
    Martell, Kevin
    Chung, Hans
    Morton, Gerard
    Vesprini, Danny
    Tseng, Chia -Lin
    Szumacher, Ewa
    Cheung, Patrick
    Chu, Will
    Liu, Stanley
    Loblaw, Andrew
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2022, 16 (08): : E437 - E442
  • [3] Putting Breast Cancer Patients First
    Grobmyer, Stephen R.
    Abraham, Jame
    BREAST JOURNAL, 2017, 23 (02): : 125 - 126
  • [4] Predictors of Gleason score upgrading in patients with a biopsy diagnosis of grade group 1 prostate cancer
    Esen, Baris
    Gurses, Bengi
    Ozkan, Arif
    Kilic, Mert
    Kordan, Yakup
    Esen, Tarik
    Baydar, Dilek E. R. T. O. Y.
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2025, 55 (01)
  • [5] RISKS OF GRADE RECLASSIFICATION AMONG PATIENTS WITH GLEASON GRADE GROUP 1 PROSTATE CANCER AND PI-RADS 5 FINDINGS ON PROSTATE MRI
    Sundaresan, Vinaik Mootha
    Webb, Lindsey
    Rabil, Maximilian
    Golos, Aleksandra
    Sutherland, Ryan
    Sprenkle, Preston
    Kim, Isaac
    Leapman, Michael
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S79 - S79
  • [6] Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRI
    Sundaresan, Vinaik Mootha
    Webb, Lindsey
    Rabil, Maximilian
    Golos, Aleksandra
    Sutherland, Ryan
    Bailey, Jonell
    Rajwa, Pawel
    Seibert, Tyler M.
    Loeb, Stacy
    Cooperberg, Matthew R.
    Catalona, William J.
    Sprenkle, Preston C.
    Kim, Isaac Y.
    Leapman, Michael S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03) : 193e19 - 193e26
  • [7] MRI characteristics predict risk of pathological upgrade in patients with ISUP grade group 1 prostate cancer
    Boschheidgen, M.
    Schimmoeller, L.
    Radtke, J. P.
    Kastl, R.
    Jannusch, K.
    Lakes, J.
    Drewes, L. R.
    Radke, K. L.
    Esposito, I.
    Albers, P.
    Antoch, G.
    Ullrich, T.
    Al-Monajjed, R.
    EUROPEAN RADIOLOGY, 2025, 35 (04) : 2170 - 2179
  • [8] What is cancer? A focus on Grade Group 1 prostate cancer
    Talwar, Ruchika
    Akinsola, Olutiwa
    Penson, David F.
    BJU INTERNATIONAL, 2024, 133 (04) : 360 - 364
  • [9] Physician Perception of Grade Group 1 Prostate Cancer
    Saoud, Ragheed
    Woranisarakul, Varat
    Paner, Gladell P.
    Ramotar, Matthew
    Berlin, Alejandro
    Cooperberg, Matthew
    Eggener, Scott E.
    EUROPEAN UROLOGY FOCUS, 2023, 9 (06): : 966 - 973
  • [10] Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillance
    Kaye, Deborah R.
    Qi, Ji
    Morgan, Todd M.
    Linsell, Susan
    Ginsburg, Kevin B.
    Lane, Brian R.
    Montie, James E.
    Cher, Michael L.
    Miller, David C.
    BJU INTERNATIONAL, 2019, 123 (05) : 846 - 853
12345